no image available Dickens & Co. "Breaking the Shackles: Unpacking the Impact of Hydroxyurea on Hospitalization Rates for Sickle Cell Disease in the US" "A Decade of Progress: How the FDA's Approval of Hydroxyurea Altered the Hospitalization Landscape for Sickle Cell Patients" Price: 29.00€